Home / Intelligence / White Papers / Diversity in Clinical Trials Participation: A Life Sciences Perspective
Providing optimal care to all patients is an imperative that unites the various, interconnected parts of the medical field, from primary care to the pharmaceutical industry to the work of large academic medical centers. Over the past 30 years, there have been exceptional advances in care, treatment, diagnostics, and early identification of disease. Unfortunately, even with these many technological advances, addressing the importance of diversity has been lagging. Since the advent of clinical trials, recruitment has been largely centered on White populations. Although over 40% of the US population is currently comprised of ethnic and racial minorities, quite often only 5 to 10% of clinical trial participants represent any minority population. The disparity is striking and can also leave care providers with a detrimental lack of foundational information, not only with respect to what therapeutics might be most effective in minority patients, but also leave gaps and unanswered questions regarding potential adverse events and contraindications.
Thank you for your interest. Continue reading the Trinity Whitepaper – Diversity in Clinical Trials Participation: A Life Sciences Perspective below.
Related Intelligence
Podcasts
Measures the Life Sciences Industry Can Take to Facilitate Diversity in Clinical Trials
The importance of ensuring diversity in clinical trials is undisputed, but barriers across the healthcare ecosystem still exist; what can healthcare regulators, policy makers, and manufacturers do to overcome challenges when recruiting clinical trial participants? Host, Matthew Rube, a Senior Consultant at Trinity Life Sciences, joins two of the subject-matter experts that authored Trinity Life […]
Listen Now
White Papers
Women Representation in Life Science Consulting Leadership
Over the past few years, there has been a spotlight on gender representation in leadership in a wide range of industries. Women are underrepresented in healthcare and biotech companies, despite evidence showing that companies that don’t have equitable representation perform worse compared to those that do. While this is recognized, there is a lack of […]
Read More
Webinars
Gender Equity in Commercial Executive Roles Recording
Available On Demand
A diverse workforce signals competent management for investors and is a better reflection of your customers.” – VP, Commercial Operations TGaS Advisors, a division of Trinity Life Sciences, partnered with EMD Serono to develop Company and Pipeline Development Scorecards from a benchmark study of life sciences compared to ex-industry best practice research, including surveys/interviews with […]
Watch Now